Indivior (INDV)

Sector:

Pharma and Biotech

Index:

FTSE 250

 837.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 1,764.00p
  • 52 Week Low: 576.50p
  • Currency: UK Pounds
  • Shares Issued: 126.53m
  • Volume: 0
  • Market Cap: £1,059.03m
  • RiskGrade: 314
  • Beta: 1.53

Indivior receives settlement approval for antitrust litigation

By Iain Gilbert

Date: Thursday 29 Feb 2024

LONDON (ShareCast) - (Sharecast News) - Pharmaceuticals business Indivior has received final court approval for a landmark settlement in an antitrust multi-district litigation with the direct purchaser class.
Indivior said on Thursday that on 27 February, the United States District Court for the Eastern District of Pennsylvania entered an order granting final judgement and order of dismissal approving its direct purchaser class settlement and dismissing direct purchaser class claims.

The FTSE 250-listed group noted that the ruling, which follows a $385.0m settlement agreement in October 2023, now concludes the antitrust multi-district litigation .

As of 0945 GMT, Indivior shares were up 0.99% at 1,736.0p.



Reporting by Iain Gilbert at Sharecast.com

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Indivior Market Data

Currency UK Pounds
Share Price 837.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 1,764.00p
52 Week Low 576.50p
Volume 0
Shares Issued 126.53m
Market Cap £1,059.03m
Beta 1.53
RiskGrade 314

Indivior Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
56.93% below the market average56.93% below the market average56.93% below the market average56.93% below the market average56.93% below the market average
16% below the sector average16% below the sector average16% below the sector average16% below the sector average16% below the sector average
Price Trend
66.02% above the market average66.02% above the market average66.02% above the market average66.02% above the market average66.02% above the market average
42.86% below the sector average42.86% below the sector average42.86% below the sector average42.86% below the sector average42.86% below the sector average
Income Not Available
Growth
54.56% above the market average54.56% above the market average54.56% above the market average54.56% above the market average54.56% above the market average
Sector averageSector averageSector averageSector averageSector average

What The Brokers Say

Strong Buy 2
Buy 2
Neutral 0
Sell 0
Strong Sell 0
Total 4
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Indivior Dividends

No dividends found

Trades for --2024

Time Volume / Share Price
0 @ 0.000p

Indivior Key Personnel

CEO Mark Crossley
Chair Graham Hetherington

Top of Page